450 related articles for article (PubMed ID: 23047694)
21. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.
Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A
J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.
Hinkel R; Penzkofer D; Zühlke S; Fischer A; Husada W; Xu QF; Baloch E; van Rooij E; Zeiher AM; Kupatt C; Dimmeler S
Circulation; 2013 Sep; 128(10):1066-75. PubMed ID: 23897866
[TBL] [Abstract][Full Text] [Related]
23. Comparison of different chemically modified inhibitors of miR-199b in vivo.
Duygu B; Juni R; Ottaviani L; Bitsch N; Wit JBM; de Windt LJ; da Costa Martins PA
Biochem Pharmacol; 2019 Jan; 159():106-115. PubMed ID: 30452907
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic inhibition of microRNA-34a ameliorates aortic valve calcification via modulation of Notch1-Runx2 signalling.
Toshima T; Watanabe T; Narumi T; Otaki Y; Shishido T; Aono T; Goto J; Watanabe K; Sugai T; Takahashi T; Yokoyama M; Kinoshita D; Tamura H; Kato S; Nishiyama S; Arimoto T; Takahashi H; Miyamoto T; Sadahiro M; Watanabe M
Cardiovasc Res; 2020 Apr; 116(5):983-994. PubMed ID: 31393559
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
26. PEI-complexed LNA antiseeds as miRNA inhibitors.
Thomas M; Lange-Grünweller K; Dayyoub E; Bakowsky U; Weirauch U; Aigner A; Hartmann RK; Grünweller A
RNA Biol; 2012 Aug; 9(8):1088-98. PubMed ID: 22894918
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure.
Montgomery RL; Hullinger TG; Semus HM; Dickinson BA; Seto AG; Lynch JM; Stack C; Latimer PA; Olson EN; van Rooij E
Circulation; 2011 Oct; 124(14):1537-47. PubMed ID: 21900086
[TBL] [Abstract][Full Text] [Related]
28. Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice.
Morihara H; Yamamoto T; Oiwa H; Tonegawa K; Tsuchiyama D; Kawakatsu I; Obana M; Maeda M; Mohri T; Obika S; Fujio Y; Nakayama H
J Cardiovasc Pharmacol Ther; 2017 May; 22(3):273-282. PubMed ID: 27811197
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-328 as a regulator of cardiac hypertrophy.
Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
[TBL] [Abstract][Full Text] [Related]
30. Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
Murphy BL; Obad S; Bihannic L; Ayrault O; Zindy F; Kauppinen S; Roussel MF
Cancer Res; 2013 Dec; 73(23):7068-78. PubMed ID: 24145352
[TBL] [Abstract][Full Text] [Related]
31. Ultrasound and Microbubble-targeted Delivery of a microRNA Inhibitor to the Heart Suppresses Cardiac Hypertrophy and Preserves Cardiac Function.
Kopechek JA; McTiernan CF; Chen X; Zhu J; Mburu M; Feroze R; Whitehurst DA; Lavery L; Cyriac J; Villanueva FS
Theranostics; 2019; 9(23):7088-7098. PubMed ID: 31660088
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat.
Piegari E; Russo R; Cappetta D; Esposito G; Urbanek K; Dell'Aversana C; Altucci L; Berrino L; Rossi F; De Angelis A
Oncotarget; 2016 Sep; 7(38):62312-62326. PubMed ID: 27694688
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly.
Ai J; Zhang R; Gao X; Niu HF; Wang N; Xu Y; Li Y; Ma N; Sun LH; Pan ZW; Li WM; Yang BF
Cardiovasc Res; 2012 Aug; 95(3):385-93. PubMed ID: 22719074
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.
Zhou Q; Schötterl S; Backes D; Brunner E; Hahn JK; Ionesi E; Aidery P; Sticht C; Labeit S; Kandolf R; Gawaz M; Gramlich M
Int J Cardiol; 2017 Mar; 230():634-641. PubMed ID: 28065693
[TBL] [Abstract][Full Text] [Related]
35. HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility.
Williams AL; Walton CB; MacCannell KA; Avelar A; Shohet RV
Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H554-H565. PubMed ID: 30575439
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological Silencing of MicroRNA-152 Prevents Pressure Overload-Induced Heart Failure.
LaRocca TJ; Seeger T; Prado M; Perea-Gil I; Neofytou E; Mecham BH; Ameen M; Chang ACY; Pandey G; Wu JC; Karakikes I
Circ Heart Fail; 2020 Mar; 13(3):e006298. PubMed ID: 32160771
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-101a suppresses fibrotic programming in isolated cardiac fibroblasts and in vivo fibrosis following trans-aortic constriction.
Zhou Y; Shiok TC; Richards AM; Wang P
J Mol Cell Cardiol; 2018 Aug; 121():266-276. PubMed ID: 30053527
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of microRNA-146a attenuated heart failure in myocardial infarction rats.
He J; Lu Y; Song X; Gong X; Li Y
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31763669
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4.
Huang Y; Qi Y; Du JQ; Zhang DF
Expert Opin Ther Targets; 2014 Dec; 18(12):1355-65. PubMed ID: 25322725
[TBL] [Abstract][Full Text] [Related]
40. Strand and Cell Type-specific Function of microRNA-126 in Angiogenesis.
Zhou Q; Anderson C; Hanus J; Zhao F; Ma J; Yoshimura A; Wang S
Mol Ther; 2016 Oct; 24(10):1823-1835. PubMed ID: 27203443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
